Navigation Links
Autism focus of prize winning research
Date:11/27/2007

The differing rate of development of children with Autism is the focus of the research of one of the 2007 Michael Young Prize winners, awarded by the Economic and Social Research Council (ESRC) and the Young Foundation.

Previously most research in this area has focussed on the causes of autism rather than understanding it as a developmental disorder. By following a group of autistic children over a period of three years Dr Elizabeth Pellicano, from Bristol University, found that there was no uniform pattern of development.

Dr Pellicano commented "I am delighted to receive this prize. Not only does it recognise my work with children with autism, but it also recognises the significance of charting the development of autism the changes that take place across time, and the types of factors that play a role in shaping such changes.

My research findings bring hope to parents, teachers, and professionals working with young people with autism. They show that children with autism can make positive gains over a relatively short time period. In particular, childrens improvements in social interactions were especially impressive. They were chattier than previously, some were beginning to form friendships, and most showed fewer unusual behaviours and interests. We need to identify why these improvements took places, and how we can foster them further.

Teasing apart the types of factors that shape changes across time and particularly those that promote childrens well-being demands a research programme that follows children and families across time. This longitudinal research is of critical importance to the understanding of autism as a developmental condition.

Conceived in honour of the founder of the ESRC, the late Lord Michael Young, the prize aims to reward and encourage early career researchers whose work offers genuine new insights and is likely to have an impact beyond academia. Elizabeth wins 3,000 to help her communic
'/>"/>

Contact: Alexandra Saxon
alexandra.saxon@esrc.ac.uk
01-793-413-032
Economic & Social Research Council
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Research may unlock mystery of autisms origin in the brain
2. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
3. Rain Man mice provide model for autism
4. Houston Texans Star Players Ahman Green and Matt Schaub Help Easter Seals, Avondale House and Local Families Tackle Autism
5. Study shows autism symptoms can improve into adulthood
6. Brain Imaging Expert Recruited to Study Autism at The Childrens Hospital of Philadelphia
7. USC granted $8.4 million for autism research
8. Autism Speaks Applauds Supreme Court Decision Upholding Families Right to Challenge IEPs Without First Trying Out School District Proposed Placement
9. Reliant Energy, Houston Texans Ahman Green and Matt Schaub Team to Hold News Conference, Book Signing to Raise Awareness about Autism
10. Jenny McCarthy Featured at National Autism Conference in Atlanta, November 9
11. San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... (PRWEB) March 04, 2015 Alliance Healthcare ... and wellness for those in need in San Diego ... local organizations through its Mission Support Grants program with ... non-profit organizations applied for AHF’s Mission Support Grants program. ... AHF’s board of trustees and program committee, as well ...
(Date:3/4/2015)... Houston, Texas (PRWEB) March 04, 2015 ... blog , Endometriosis can be a painful ... endometrium) starts spreading outside of the uterus leading to ... and their families. Endometriosis can have a terrible effect ... symptoms. It is also the most common cause of ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Organic Valley, the ... brand, today announced its cause campaign to Save the Bros, ... and is making a difference to Bros everywhere. To ... Youtube and Facebook. The video was named Adweek’s best ... in Forbes, Mashable and Digiday, among other media outlets. ...
(Date:3/4/2015)... Springfield, VA (PRWEB) March 04, 2015 ... announce that John Dvorak has joined the ... responsible for charting the technology focus for the company, ... , Mr. Dvorak brings 20 years of experience as ... he served in diverse roles at the FBI including ...
(Date:3/4/2015)... 2015 The Alliance for Regenerative ... its upcoming fifth annual Advanced Therapies Summit next ... event this year will feature five expert-led interactive ... the field’s leading companies and organizations. , ... and clinical researchers from the advanced therapies community ...
Breaking Medicine News(10 mins):Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3
... drug Rimonabant (Acomplia) a selective cannabinoid receptor blocker (CB1), ... Supplementation with 20 milligrams of rimonabant a day resulted ... circumference -- a marker of cardiovascularly dangerous visceral fat. ... prevalence of metabolic syndrome in overweight/obese patients. ...
... benefit more from treatment combining cognitive behavioral therapy with ... physicians. ,Panic disorder is one of the most ... patients meeting the criteria for panic disorder were randomly ... combining medication and up to six sessions of cognitive-behavioral ...
... A new study shows people suffering from the bone-thinning ... having celiac disease //, a condition in which people ... for celiac disease can markedly improve bone mineral density, ... celiac disease also tend to have thinning bones, but ...
... gene variant that may increase the risk of late-onset ... improved understanding of the disease and new prevention and ... that specific changes in the gene in a protein ... Alzheimer’s. ,In previous studies, researchers studied Alzheimer’s patients ...
... chemotherapy (IPHC) and is currently //being considered as the ... treatment are connected to a series of tubes and ... the abdominal cavity for a couple of houirs. ... drug while the direct contact helps kill the carcinogenic ...
... Researchers say they may have discovered a potential form ... ,More than 1 million Americans are estimated to ... forms of inflammatory bowel disease. The conditions, can be ... the digestive tracts. Patients with inflammatory bowel disease suffer ...
Cached Medicine News:
(Date:3/4/2015)... , March 4, 2015 Asterias Biotherapeutics, ... the emerging field of regenerative medicine, today announced that ... will ring The Opening Bell ® of the ... 2015. Asterias began trading as an NYSE MKT listed ... York Stock Exchange is a trusted partner to Asterias ...
(Date:3/4/2015)... OAKS, Calif. , March 4, 2015 ... Board of Directors today declared a $0.79 per share ... will be paid on June 5, 2015, to all ... on May 14, 2015.  About Amgen ... for patients suffering from serious illnesses by discovering, developing, ...
(Date:3/4/2015)... 4, 2015  NxStage Medical, Inc. (Nasdaq: NXTM ... that Jeffrey H. Burbank , Chief Executive Officer, will ... Miami, FL on Wednesday, March 11 th ... the event will be made available at http://ir.nxstage.com ... NxStage NxStage Medical, Inc. (Nasdaq: NXTM ...
Breaking Medicine Technology:Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 2Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 3Amgen Announces 2015 Second Quarter Dividend 2Amgen Announces 2015 Second Quarter Dividend 3NxStage to Present at the Barclays Capital Global Healthcare Conference 2
... Based on its recent analysis of the personal emergency ... with the 2010 North American Frost & Sullivan Award ... BeClose System and its applications in the "aging independently" ... While PERS have provided a health monitoring service for ...
... Inc. (Nasdaq: OPTR ) today announced that the ... the Company,s New Drug Application (NDA) for fidaxomicin for the ... reducing the risk of recurrence when used for treatment of ... for six-month Priority Review, and has assigned a Prescription Drug ...
Cached Medicine Technology:Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America 2Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America 3Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America 4Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI) 2Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI) 3Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI) 4
Shandon Slide Mailers and Envelopes...
Shandon Stackable Slide Storage Cabinet...
Shandon Slide File Storage System...
Shandon Plastic Slide Boxes...
Medicine Products: